190 related articles for article (PubMed ID: 24787297)
1. Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal.
Seftor EA; Seftor REB; Weldon D; Kirsammer GT; Margaryan NV; Gilgur A; Hendrix MJC
Semin Oncol; 2014 Apr; 41(2):259-266. PubMed ID: 24787297
[TBL] [Abstract][Full Text] [Related]
2. Human breast and melanoma cancer stem cells biomarkers.
La Porta CA; Zapperi S
Cancer Lett; 2013 Sep; 338(1):69-73. PubMed ID: 22445909
[TBL] [Abstract][Full Text] [Related]
3. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
4. Embryonic signaling in melanoma: potential for diagnosis and therapy.
Strizzi L; Hardy KM; Kirsammer GT; Gerami P; Hendrix MJ
Lab Invest; 2011 Jun; 91(6):819-24. PubMed ID: 21464823
[TBL] [Abstract][Full Text] [Related]
5. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.
Lonardo E; Hermann PC; Mueller MT; Huber S; Balic A; Miranda-Lorenzo I; Zagorac S; Alcala S; Rodriguez-Arabaolaza I; Ramirez JC; Torres-Ruíz R; Garcia E; Hidalgo M; Cebrián DÁ; Heuchel R; Löhr M; Berger F; Bartenstein P; Aicher A; Heeschen C
Cell Stem Cell; 2011 Nov; 9(5):433-46. PubMed ID: 22056140
[TBL] [Abstract][Full Text] [Related]
6. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of CD133(+) melanoma stem-like cells conferring resistance to taxol: An insight into the mechanisms of their resistance and response.
El-Khattouti A; Selimovic D; Haïkel Y; Megahed M; Gomez CR; Hassan M
Cancer Lett; 2014 Feb; 343(1):123-33. PubMed ID: 24080340
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
9. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Melanoma with Stem Cell Properties.
Seftor EA; Margaryan NV; Seftor REB; Hendrix MJC
Adv Exp Med Biol; 2019; 1139():105-114. PubMed ID: 31134497
[TBL] [Abstract][Full Text] [Related]
11. Research progression of CD133 as a marker of cancer stem cells.
Zhang H; Li SY
Chin J Cancer; 2010 Mar; 29(3):243-7. PubMed ID: 20193104
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63α.
Portillo-Lara R; Alvarez MM
PLoS One; 2015; 10(6):e0130118. PubMed ID: 26110651
[TBL] [Abstract][Full Text] [Related]
13. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic diversity of patient-derived melanoma populations in stem cell medium.
Sztiller-Sikorska M; Hartman ML; Talar B; Jakubowska J; Zalesna I; Czyz M
Lab Invest; 2015 Jun; 95(6):672-83. PubMed ID: 25867763
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma.
Guth AM; Deogracias M; Dow SW
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):132-40. PubMed ID: 25146881
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
17. Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells.
Li H; Chen J; Wang X; He M; Zhang Z; Cen Y
Oncol Rep; 2018 Jun; 39(6):2855-2864. PubMed ID: 29693169
[TBL] [Abstract][Full Text] [Related]
18. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
20. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma.
Rappa G; Fodstad O; Lorico A
Stem Cells; 2008 Dec; 26(12):3008-17. PubMed ID: 18802032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
